These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 4170883)

  • 1. Diphenylhydantoin prevention of arrhythmias in the digitalis-sensitized dog after direct-current cardioversion.
    Helfant RH; Scherlag BJ; Damato AN
    Circulation; 1968 Mar; 37(3):424-8. PubMed ID: 4170883
    [No Abstract]   [Full Text] [Related]  

  • 2. Electrophysiological effects of direct current countershock before and after ouabain sensitization and after diphenylhydantoin desensitization in the dog.
    Helfant RH; Scherlag BJ; Damato AM
    Circ Res; 1968 May; 22(5):615-23. PubMed ID: 5648065
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of glucagon on arrhythmias due to digitalis toxicity.
    Cohn KE; Agmon J; Gamble OW
    Am J Cardiol; 1970 Jun; 25(6):683-9. PubMed ID: 4192693
    [No Abstract]   [Full Text] [Related]  

  • 4. Digitalis-induced arrhythmias: recognition and management.
    Rios JC; Dziok CA; Ali NA
    Cardiovasc Clin; 1970; 2(2):261-79. PubMed ID: 4131127
    [No Abstract]   [Full Text] [Related]  

  • 5. [Digitalic arrhythmia in dogs. I. Effect of synchronized direct current shock. II. Effect of shock with previous administration of anti-arrhythmic drugs].
    Berezovsky M; Lopez Morillas MA; Novoa F; Acuñá E; Marrone V
    Prensa Med Argent; 1972 Mar; 59(7):266-74. PubMed ID: 5031936
    [No Abstract]   [Full Text] [Related]  

  • 6. The clinical use of diphenylhydantoin (dilantin) in the treatment and prevention of cardiac arrhythmias.
    Helfant RH; Seuffert GW; Patton RD; Stein E; Damato AN
    Am Heart J; 1969 Mar; 77(3):315-23. PubMed ID: 4179761
    [No Abstract]   [Full Text] [Related]  

  • 7. Ventricular tachycardia.
    Willerson JT; Yurchak PM; DeSanctis RW
    Cardiovasc Clin; 1970; 2(2):69-86. PubMed ID: 4131129
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of diphenylhydantoin on auriculoventricular and intraventricular conduction in humans].
    Benaim R; Chapelle M; Chiche P
    Ann Cardiol Angeiol (Paris); 1972; 21(4):379-88. PubMed ID: 4119867
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical applications of antiarrhythmic drugs.
    Lavenne F; de Jonghe D
    Acta Cardiol Suppl; 1980; (25):27-42. PubMed ID: 6155012
    [No Abstract]   [Full Text] [Related]  

  • 10. [Combination therapy with anti-arrhythmia agents].
    Kettner W; Götze C
    Z Arztl Fortbild (Jena); 1986; 80(21):889-92. PubMed ID: 2436386
    [No Abstract]   [Full Text] [Related]  

  • 11. [Anti-arrhythmia agents].
    Kaufmann G
    Med Klin; 1974 May; 69(18):778-86. PubMed ID: 4134645
    [No Abstract]   [Full Text] [Related]  

  • 12. The diagnosis, significance, and management of A-V nodal rhythms.
    Schamroth L
    Cardiovasc Clin; 1970; 2(2):145-62. PubMed ID: 4131123
    [No Abstract]   [Full Text] [Related]  

  • 13. The clinical pharmacology and therapeutic applications of the antiarrhythmic drugs.
    Mason DT; Spann JF; Zelis R; Amsterdam EA
    Clin Pharmacol Ther; 1970; 11(4):460-80. PubMed ID: 4913865
    [No Abstract]   [Full Text] [Related]  

  • 14. [Injectable diphenylhydantoin in cardiology. Experimental study].
    Quiret JC; Bens JL; Duboisset M; Lesbre P; Bernasconi P
    Arch Mal Coeur Vaiss; 1974 Jan; 67(1):87-96. PubMed ID: 4211204
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-arrhythmic action of dilazep. Action on experimental arrhythmias induced by g-strophanthin (ouabain), epinephrine and aconitine.
    Sano N; Kawada M; Fukutomi Y
    Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1893-8. PubMed ID: 4141624
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies with quinidine and digoxin on the cardiac vulnerable period.
    McCawley EL; Dick HL; Reeves M
    Proc West Pharmacol Soc; 1966; 9():9-12. PubMed ID: 5958505
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapy of arrhythmias. New anti-arrhythmia agents].
    Scholz H
    Verh Dtsch Ges Herz Kreislaufforsch; 1981; 47():18-33. PubMed ID: 6173967
    [No Abstract]   [Full Text] [Related]  

  • 18. [Present possibilities of the treatment of malignant ventricular arrhythmia in coronary disease].
    Breithardt G; Borggrefe M
    Dtsch Med Wochenschr; 1985 Dec; 110(51-52):1987-92. PubMed ID: 2416523
    [No Abstract]   [Full Text] [Related]  

  • 19. Antiarrhythmic action of atropine.
    Viana AP; Osswald W
    Arch Int Pharmacodyn Ther; 1971 Aug; 192(2):238-46. PubMed ID: 4106043
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of ventricular extrasystoles and tachyarrhythmias in acute myocardial infarction.
    Selzer A; Cohn KE
    Annu Rev Med; 1970; 21():47-58. PubMed ID: 4192969
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.